As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

A new study found bariatric ... and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

They are prescription-only drugs, but can also ... by patients with diabetes in 2022 and 2017, respectively, but has not yet done so specifically for weight loss. Wegovy and Zepbound were approved ...

I struggled with my weight my entire life, but my recent weight loss ... the prescription, but I was lucky if I could actually get it.) Due to the high cost, I stopped taking the medication ...

The type 2 diabetes medication ... drug—off-label for weight loss. But how does metformin work, and how much weight can you ...

Jelly Roll is keeping the nickname he's had since childhood, but his newfound focus on his health has the 2024 CMA Awards nominee altering his relationship with food and feeling better than ever.

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...